| Literature DB >> 20009309 |
Pradnya D Patil1, Tanmay S Panchabhai, Sagar C Galwankar.
Abstract
Human bites are frequently overlooked in making a diagnosis in the emergency room. They are particularly notorious due to the polymicrobial nature of human saliva inoculated in the wound and the risk they pose for transmission of infectious diseases. Early treatment, appropriate prophylaxis and surgical evaluation are the key to achieving desired treatment outcomes. Through this article, we have tried to summarize the diagnostic features, complications as well as the recommended treatment alternatives for human bites based on the current available evidence.Entities:
Year: 2009 PMID: 20009309 PMCID: PMC2776367 DOI: 10.4103/0974-2700.55331
Source DB: PubMed Journal: J Emerg Trauma Shock ISSN: 0974-2700
Patients with bite wounds who may benefit from inpatient therapy
| Hand, foot or face wounds | Patients > 50 years |
| Scalp involvement | Immunosuppressed patients |
| Bone/joint involvement | Chronic alcoholism |
| Puncture wounds | Diabetes mellitus |
| Crush injuries | Vascular disease |
| Delayed treatment | Pre-existing edema of the affected extremity |
Antibiotic management of human bites[1]
| Antibiotic therapy | |
|---|---|
| Hand bites, high risk bites | |
| Adults | First parental dose, ampicillin–sulbactam (3 g) or cefoxitin (1 g) or ertapenam (1 g) followed by amoxicillin–clavulanate (875/125 mg PO q 12 h) for 3-5 days |
| or | |
| First parental dose of clindamycin (600 mg) followed by clindamycin (300 mg PO q 8 h) plus a fluoroquinolone (ciprofloxacin, 500 mg PO q 12 h, or levofloxacin, 750 mg/d PO, or moxifloxacin, 400 mg/d PO) for 3-5 days, | |
| or | |
| If parental therapy cannot be given, appropriate oral antibiotics (e.g., amoxicillin–clavulanate, 875/125 mg PO q 12h) for 3-5 days | |
| Children | First parental dose: Ampicillin–sulbactam (50 mg/kg as ampicillin to a maximum of 3 g) followed by amoxicillin–clavulanate (>40 kg: 875/125 mg PO q 12 h; >3 mo and <40 kg: 45 mg/kg/d PO divided q 12 h or 40 mg/kg/d PO divided q 8 h) for 3-5 days |
| or | |
| First parental dose: Clindamycin (5-10 mg/kg IV to a maximum of 600 mg) followed by clindamycin (10-30 mg/kg/d PO divided q 6-8 h to a maximum of 300 mg/dose) plus trimethoprim–sulfamethoxazole (8-10 mg/kg of trimethoprim/d PO divided q 12 h) for 3-5 days | |
| Human bites, infected | |
| Adults | Ampicillin–sulbactam (3 g IV q 4-6 h) or cefoxitin (1 g IV q 6-8 h) or ertapenam (1 g/d IV) |
| Subsequent oral therapy or initial therapy for minor infection: Amoxicillin–clavulanate (875/125 mg PO q 12 h) | |
| Children | Ampicillin–sulbactam (100-200 mg/kg/d IV divided q 6 h to a maximum of 3 g/dose) |
| or | |
| Cefoxitin or ticarcillin–clavulanate can be given alternatively | |
| Subsequent oral therapy or initial therapy for minor infection: Amoxicillin–clavulanate (> 40 kg: 875/125 mg PO q 12 h; > 3 mo and < 40 kg: 45 mg/kg/d divided q12 h or 40 mg/kg/d divided q 8 h) | |